Pfizer Sustainability Profile
Pfizer Inc., a leading global biopharmaceutical company headquartered in the United States, has been at the forefront of medical innovation since its founding in 1849. With a strong presence in North America, Europe, and Asia, Pfizer operates across various sectors, including vaccines, oncology, and rare diseases. The company is renowned for its core products, such as the COVID-19 vaccine and groundbreaking cancer therapies, which leverage advanced biotechnology to address unmet medical needs. Pfizer's commitment to research and development has positioned it as a market leader, consistently achieving significant milestones in drug discovery and patient care. With a robust portfolio and a reputation for quality, Pfizer continues to shape the future of healthcare, making a profound impact on global health outcomes.
DitchCarbon Score
How does Pfizer's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Pfizer's score of 75 is higher than 84% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Pfizer's reported carbon emissions
In 2024, Pfizer reported total greenhouse gas emissions of approximately 6,132,180,000 kg CO2e globally, which includes 613,218,000 kg CO2e from Scope 1 and 465,128,000 kg CO2e from Scope 2 emissions. The company also disclosed significant Scope 3 emissions, amounting to approximately 3,536,300,000 kg CO2e. Pfizer has set ambitious climate commitments, aiming for a 46% reduction in absolute Scope 1 and 2 emissions by 2030 from a 2019 baseline. This target is aligned with a 1.5°C trajectory and includes a commitment to source 100% renewable electricity by 2030. Additionally, Pfizer aims to reduce Scope 3 emissions related to business travel by 25% and upstream transportation and distribution by 10% by 2025, both from a 2019 baseline. The company is also committed to achieving net-zero emissions across its value chain by 2040, with a target to reduce overall emissions by 90% from 2019 levels. These targets have been approved by the Science Based Targets initiative (SBTi) and reflect Pfizer's dedication to sustainability and climate action. Pfizer's headquarters is located in the United States, and its climate initiatives are part of a broader commitment to environmental responsibility within the pharmaceutical industry.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 964,846,000 | - | - | - | - | - | - | - | 000,000,000 | - | - | - | 000,000,000 |
| Scope 2 | 883,814,000 | - | - | - | - | - | - | - | 000,000,000 | - | - | - | 000,000,000 |
| Scope 3 | - | - | - | - | - | - | - | 000,000,000 | 0,000,000,000 | 00,000,000 | 00,000,000 | 000,000,000 | 0,000,000,000 |
How Carbon Intensive is Pfizer's Industry?
How Carbon Intensive is Pfizer's Location?
Pfizer's Scope 3 Categories Breakdown
Pfizer's Scope 3 emissions, which increased significantly last year and increased by approximately 821% since 2019, demonstrating supply chain emissions tracking. Most of their carbon footprint comes from suppliers and value chain emissions, with Scope 3 emissions accounting for 77% of total emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 79% of Scope 3 emissions.
Top Scope 3 Categories
Pfizer's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Pfizer has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
GlaxoSmithKline Pakistan Limited
GlaxoSmithKline Pharmaceuticals Limited
Frequently Asked Questions
Common questions about Pfizer's sustainability data and climate commitments